What is Pfizer's all other primary care — revenues:?

Pfizer (PFE) reported all other primary care — revenues: of $654.00M in Q1 2026.

How has Pfizer's all other primary care — revenues: changed year-over-year?

Pfizer's all other primary care — revenues: increased by 7.4% year-over-year, from $609.00M to $654.00M.

What is the long-term trend for Pfizer's all other primary care — revenues:?

Over 3 years (2022 to 2025), Pfizer's all other primary care — revenues: has grown at a 4.2% compound annual growth rate (CAGR), from $2.52B to $2.86B.

Products & Services · Revenues:

All other Primary Care — Revenues:

Pfizer All other Primary Care — Revenues: decreased by 17.1% to $654.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.4%, from $609.00M to $654.00M. Over 3 years (FY 2022 to FY 2025), All other Primary Care — Revenues: shows an upward trend with a 4.2% CAGR.

Analysis

StatementSegment

First reportedQ1 2020

Last reportedQ1 2026May 5, 2026

Rolls up toTotal Revenue

Metric ID: pfe_segment_all_other_primary_care_revenues

Historical Data

19 periods

	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$479.00M	$1.11B	$507.00M	$519.00M	$485.00M	$1.01B	$785.00M	$616.00M	$670.00M	$1.05B	$770.00M	$759.00M	$742.00M	$787.00M	$609.00M	$736.00M	$721.00M	$789.00M	$654.00M
QoQ Change	—	+132.6%	-54.5%	+2.4%	-6.6%	+108.2%	-22.3%	-21.5%	+8.8%	+57.3%	-26.9%	-1.4%	-2.2%	+6.1%	-22.6%	+20.9%	-2.0%	+9.4%	-17.1%
YoY Change	—	—	—	—	+1.3%	-9.3%	+54.8%	+18.7%	+38.1%	+4.4%	-1.9%	+23.2%	+10.7%	-25.3%	-20.9%	-3.0%	-2.8%	+0.3%	+7.4%

Range$479.00M – $1.11B

CAGR+7.2%

Avg YoY Growth+6.4%

Median YoY Growth+1.3%

Frequently Asked Questions

What is Pfizer's all other primary care — revenues:?: Pfizer (PFE) reported all other primary care — revenues: of $654.00M in Q1 2026.
How has Pfizer's all other primary care — revenues: changed year-over-year?: Pfizer's all other primary care — revenues: increased by 7.4% year-over-year, from $609.00M to $654.00M.
What is the long-term trend for Pfizer's all other primary care — revenues:?: Over 3 years (2022 to 2025), Pfizer's all other primary care — revenues: has grown at a 4.2% compound annual growth rate (CAGR), from $2.52B to $2.86B.